What Are Positrons and How Are They Used?

A positron is the antimatter counterpart of the electron: identical in mass but carrying a positive charge instead of a negative one. Predicted theoretically by Paul Dirac in 1931 and detected experimentally by Carl Anderson just a year later in cosmic rays, the positron was the first antiparticle ever confirmed to exist.1Europe PMC. 90 years after the discovery of the positron – positron emission tomography has become a unique diagnostic and theranostic tool Since that discovery, positrons have gone from a curiosity of theoretical physics to a practical tool used in hospitals, research labs, and industrial facilities around the world.

How Positrons Behave

The defining property of a positron is that it annihilates the instant it encounters an electron. When a positron and an electron meet, both particles disappear and their combined mass converts into energy in the form of two gamma-ray photons, each carrying 511 keV of energy. Those two photons fly off in almost exactly opposite directions. This annihilation event is not a rare phenomenon that requires special conditions; it happens reliably every time a positron slows down enough to interact with the abundant electrons in ordinary matter. In air or tissue, a positron typically travels only a few millimeters before finding an electron partner and vanishing.

That predictable burst of paired gamma rays is the foundation of nearly every practical use of positrons. Because the two photons leave the scene in opposite directions, detectors placed around the annihilation site can pinpoint exactly where it happened by recording both photons almost simultaneously. This geometric trick turns a subatomic self-destruction event into a precise location signal, and it is the core principle behind PET scanning.

Where Positrons Come From

Positrons do not just sit around waiting to be collected. They have to be created, and nature provides a few different mechanisms for that. The most common source in medical and research settings is radioactive decay. Certain unstable isotopes, like fluorine-18, carbon-11, and gallium-68, undergo a type of nuclear decay called beta-plus decay, in which a proton inside the nucleus converts into a neutron and releases a positron along with a neutrino. These isotopes are typically manufactured in a cyclotron, a compact particle accelerator found at many major hospitals and radiopharmacy centers.

Positrons can also be generated through a process called pair production. When a high-energy photon (a gamma ray with energy above about 1.022 MeV) passes close to an atomic nucleus, it can spontaneously convert into an electron-positron pair. The heavier the nucleus, the more likely this is to happen, with the probability scaling roughly with the square of the nuclear charge.2Radiation Physics and Chemistry. Electron–positron pair production by photons: A historical overview This is actually the reverse of annihilation: energy transforms into matter and antimatter in equal parts. Pair production happens naturally when cosmic rays slam into Earth’s atmosphere, and it can be reproduced in the lab with particle accelerators or high-energy photon sources.

A newer frontier involves using intense laser pulses to produce positron beams. Simulations based on parameters from planned facilities suggest that high-intensity lasers could generate bursts containing billions of positrons at energies above 100 MeV, with experiments already producing positrons at energies up to half a GeV.3PubMed Central. Laser-driven high-quality positron sources as possible injectors for plasma-based accelerators These laser-driven sources could eventually complement traditional accelerator-based production for advanced physics experiments.

PET Scanning and Cancer

Positron emission tomography, or PET, is by far the most widespread practical application of positrons. The idea is straightforward: attach a positron-emitting isotope to a biologically active molecule, inject it into a patient, and then detect the paired gamma rays from annihilation to map where that molecule concentrates in the body. The most commonly used tracer is FDG, a glucose-like molecule tagged with fluorine-18. Cancer cells tend to consume glucose faster than healthy tissue, so they light up on an FDG-PET scan.

PET combined with CT scanning has become a primary tool for staging cancer, checking for recurrence, and evaluating whether a treatment is working. One of its most valuable features is speed of feedback: FDG-PET can reveal whether a tumor is responding to chemotherapy before the tumor physically shrinks, giving oncologists the ability to change course earlier if a treatment is not effective.4Journal of Nuclear Medicine. 18F-FDG PET and PET/CT in the Evaluation of Cancer Treatment Response A tumor that keeps gobbling up glucose after several rounds of chemotherapy is a tumor that is not responding, and that information can appear on a PET scan weeks before it shows up on a conventional CT or MRI.

Researchers are also working on ways to image multiple biological processes in a single scan session. By combining FDG (which tracks glucose metabolism) with another tracer called FLT (which tracks cell division), clinicians could get complementary pictures of tumor behavior at once, potentially sharpening treatment decisions without subjecting patients to separate scanning sessions on different days.5PubMed Central. Single-scan dual-tracer FLT+FDG PET tumor characterization

Mapping the Brain in Alzheimer’s Disease

PET scanning has carved out a particularly important niche in neurology, especially for Alzheimer’s disease. The hallmark of Alzheimer’s is the buildup of amyloid plaques and tau tangles in the brain, and for a long time the only definitive way to confirm those features was through a brain biopsy or autopsy. Amyloid PET changed that. Using tracers that bind specifically to amyloid deposits, PET can detect plaques in a living person’s brain. This technique has been approved by the FDA, the European Medicines Agency, and regulators in other countries, and it has become a core part of the diagnostic workup for Alzheimer’s.6PubMed Central. The Role of Amyloid PET in Imaging Neurodegenerative Disorders: A Review

Beyond simple diagnosis, amyloid PET has reshaped how researchers understand dementia more broadly. Amyloid deposits turn out to play a role not only in Alzheimer’s but also in Lewy body disorders and even in some aspects of normal aging. Tau PET, a newer addition, targets the other major Alzheimer’s protein and is expected to become increasingly important for monitoring disease progression and evaluating experimental treatments.7PubMed Central. Multimodal PET Imaging of Amyloid and Tau Pathology in Alzheimer Disease and Non-Alzheimer Disease Dementias One practical consequence of these imaging advances is that drug trials for Alzheimer’s can now select patients who actually have confirmed amyloid pathology, rather than enrolling people based on clinical symptoms alone, which historically muddied trial results because some participants did not actually have the disease the drug was targeting.8PubMed. Radiotracers for Amyloid Imaging in Neurodegenerative Disease: State-of-the-Art and Novel Concepts

Theranostics and the Diagnose-Then-Treat Approach

One of the more compelling recent developments in nuclear medicine is the concept of theranostics, which pairs a diagnostic scan with a targeted treatment using the same molecular vehicle. The idea is to label a molecule that seeks out a specific type of disease tissue (say, prostate cancer cells) with a positron emitter for imaging. If the scan confirms that the molecule reaches the tumor effectively, you then swap in a therapeutic radioisotope on the same molecule and deliver a radiation dose directly to those cancer cells.

This approach emerged decades ago with radioactive iodine for thyroid disease, but it has expanded dramatically. Prostate cancer is a leading example: imaging agents that target a protein called PSMA, which is overexpressed on many prostate cancers, are used first as PET tracers to map where cancer has spread, and then as carriers for therapeutic radiation to treat those same sites.9PubMed Central. Theranostics Nuclear Medicine in Prostate Cancer The diagnostic positron scan essentially auditions the molecule for the therapeutic job. If the tracer does not accumulate in the tumor, the therapy version probably will not either, sparing the patient an ineffective treatment.

How PET Compares to Other Nuclear Imaging

PET is not the only type of nuclear medicine imaging. SPECT (single-photon emission computed tomography) also creates images based on radioactive tracers, but it detects single gamma-ray photons rather than the paired photons from positron annihilation. This difference in physics has real consequences for image quality. PET consistently delivers sharper spatial resolution and more accurate measurements of tracer concentration. In a recent quantitative comparison, the smallest test objects recovered over 80% of their true activity on a PET scan using fluorine-18, compared with roughly 20% for a standard SPECT isotope at the same size.10PubMed Central. Quantitative Comparison of SPECT and PET Performance for Clinical Theranostic Applications

In brain imaging specifically, the resolution gap matters. PET scanners used for brain studies can achieve spatial resolution around 4 mm, compared with roughly 10 mm for a typical SPECT system.11Journal of Nuclear Medicine. Direct Comparison of Spatially Normalized PET and SPECT Scans in Alzheimer’s Disease That 4 mm versus 10 mm gap makes a significant difference when you are trying to identify which specific brain region is affected by amyloid plaques or reduced metabolism. SPECT remains widely used because its tracers tend to be cheaper and have longer shelf lives, and SPECT cameras are more common in smaller hospitals. But when quantitative precision or fine anatomical detail matters, PET is the stronger tool.

Positronium and Its Emerging Uses

Before a positron annihilates with an electron, the two particles can briefly form a bound atom-like state called positronium. It is the simplest “atom” imaginable: one particle of matter and one of antimatter orbiting each other, with no nucleus at all. Positronium comes in two flavors depending on how the spins of the electron and positron align. Para-positronium, with opposite spins, self-destructs in about 125 trillionths of a second. Ortho-positronium, with aligned spins, hangs around roughly a thousand times longer before annihilating, though “longer” still means just 142 billionths of a second in vacuum.

What makes positronium interesting beyond pure physics is that its lifetime changes depending on what kind of material it forms in. Researchers have found that the ortho-positronium lifetime differs by roughly 20% in adipose (fatty) tissue compared with hepatic or muscle tissue, a distinction that could eventually be exploited for medical imaging that provides different information than a standard PET scan.12Scientific Reports. Ortho-positronium lifetime for soft-tissue classification This technique, known as positron annihilation lifetime spectroscopy, is well established in materials science for probing the size and distribution of microscopic voids and defects in solids, and its adaptation to biological tissue classification is an active area of research.

Probing Surfaces and Defects in Materials

Outside the hospital, positrons have a specialized but important role in materials science. When a positron enters a solid material, it naturally drifts toward regions where atoms are missing or improperly arranged, essentially getting trapped in vacancies and voids because those empty spaces are energetically favorable. By measuring the characteristics of the annihilation gamma rays (their energy, timing, and angular distribution), researchers can deduce the size and concentration of defects inside a material without cutting it open. This makes positron-based techniques uniquely sensitive to the kinds of nanoscale imperfections that control the electrical and mechanical properties of semiconductors, metals, and polymers.

Positrons also have a special trick for surface science. A technique called reflection high-energy positron diffraction (RHEPD) takes advantage of a phenomenon that has no equivalent in electron-based surface analysis: total reflection. Below a critical angle, positrons bounce off a material’s outermost atomic layer rather than penetrating it, which allows researchers to map the positions of surface atoms with exceptional accuracy.13Surface Science Reports. Positrons in surface physics Electrons, being negatively charged, are attracted into the surface and penetrate deeper, making them less surface-specific. This gives positron diffraction a genuine advantage for studying surface reconstructions, thin films, and catalytic surfaces at the atomic scale.

Trapping and Storing Antimatter

Using positrons for precision experiments requires collecting and storing them, which is tricky when your particles annihilate on contact with ordinary matter. Modern positron traps use electromagnetic fields to confine the particles without letting them touch any physical walls. One common approach is the Surko trap, also called a buffer gas trap, which slows incoming positrons by letting them collide with gas molecules and then captures the cooled positrons in an electric potential well. Once a batch is accumulated, the positrons can be transferred to a stronger magnetic trap for longer storage.

The GBAR experiment at CERN, which aims to measure how antimatter responds to gravity, has pushed trap technology further. Their setup uses a linear electron accelerator to generate positrons, captures them in a buffer gas trap that incorporates a silicon carbide crystal as a “remoderator” (essentially a material that re-emits slow positrons when hit by fast ones), and then stacks many pulses of positrons into a high-field Penning-Malmberg trap.14Journal of Physics: Conference Series. News from the GBAR experiment: Improved positron accumulation in a buffer gas trap with a silicon carbide remoderator Building up large clouds of trapped positrons is essential for producing enough antihydrogen atoms to perform meaningful gravity measurements.

Testing Fundamental Physics

Positrons sit at the intersection of several deep questions in physics. One of the biggest open questions about antimatter is whether it falls down under gravity the same way ordinary matter does. General relativity predicts that it should, but no one has directly measured the gravitational behavior of a neutral antimatter system with enough precision to be sure. Experiments at CERN and elsewhere are working on this problem using antihydrogen (an antiproton orbited by a positron) and positronium as test particles.15Advances in High Energy Physics. Prospects for Studies of the Free Fall and Gravitational Quantum States of Antimatter Positronium is appealing for these experiments because it is purely leptonic, meaning it does not involve the strong nuclear force, which simplifies the theoretical predictions you need to compare against.

Positrons also play a role in high-energy particle physics. Electron-positron colliders, unlike proton colliders, produce very clean collisions because neither the electron nor the positron is made of smaller constituent particles. This means the collision energy goes directly into creating new particles rather than being distributed among internal components. Future electron-positron colliders are being designed to measure properties of the Higgs boson, W and Z bosons, and the top quark with a precision that proton colliders cannot easily achieve.16International Journal of Modern Physics A. Gauge boson polarization correlations in the electron–positron annihilation process Several proposals for next-generation colliders, including the International Linear Collider and the Future Circular Collider at CERN, include electron-positron collision modes as central components of their physics programs.

Positrons in Astrophysics

Positrons are not just laboratory creatures. They are produced naturally throughout the universe, and astrophysicists detect their telltale 511 keV annihilation signal coming from various cosmic sources. The center of our own Milky Way galaxy emits a strong and steady glow at 511 keV, indicating that enormous numbers of positrons are being created and annihilated there. The exact source of all those positrons remains debated; candidates include radioactive decay of elements produced in supernovae, interactions near black holes, and certain types of stellar explosions.

Solar flares also produce positrons. When high-energy particles from a flare slam into the dense lower solar atmosphere, nuclear reactions can generate short-lived positron-emitting isotopes. The subsequent positron annihilation produces gamma-ray emission that space-based telescopes can detect, providing a window into the nuclear physics happening during flares. Studying these astrophysical positron sources helps constrain models of stellar evolution, galactic structure, and the behavior of matter under extreme conditions.

Why Positrons Are Hard to Work With

For all their usefulness, positrons present practical headaches that electrons and photons do not. The fundamental problem is that the universe is made of matter, and positrons annihilate on contact with it. You cannot store them in a jar. You cannot pipe them through ordinary tubing. Every surface, every gas molecule, every stray electron is a potential annihilation partner. This means positron experiments require ultrahigh vacuum systems and carefully designed electromagnetic traps, and even then, the number of positrons you can accumulate at one time is limited compared with the astronomical number of electrons available from a simple wire.

Production rates also remain a bottleneck. Medical cyclotrons produce fluorine-18 in sufficient quantities for PET scanning, but those positrons are used one at a time as the isotope decays inside the patient. For experiments that need dense clouds of free positrons, like antihydrogen production or precision spectroscopy of positronium, the supply chain is much more constrained. Reactor-based and accelerator-based positron sources can produce millions of positrons per second, but accumulating billions of them in a trap takes hours or days. The laser-driven sources mentioned earlier may eventually help close this gap, but they are still in the experimental phase.

Temperature is another concern. Freshly produced positrons are typically fast-moving, and many applications need them slow. Moderator materials, usually thin films of solid neon or certain metal oxides, can re-emit positrons at much lower energies, but the conversion efficiency is often only a few percent. Improving moderator efficiency is an ongoing engineering challenge that directly limits the performance of positron beams for surface science, defect analysis, and antimatter gravity experiments.